Core Laboratories (CLB) News Today $19.53 -0.42 (-2.11%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Royce & Associates LP Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB)Royce & Associates LP raised its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 9.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,021,121 shares of the oil and gas company's stockNovember 16 at 7:17 AM | marketbeat.comStockNews.com Upgrades Core Laboratories (NYSE:CLB) to "Hold"November 11, 2024 | americanbankingnews.comVan ECK Associates Corp Has $7.13 Million Holdings in Core Laboratories Inc. (NYSE:CLB)Van ECK Associates Corp decreased its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 22.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 417,384 shares of the oil and gas companyNovember 8, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Upgraded to Hold at StockNews.comStockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a report on Thursday.November 7, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Upgraded by StockNews.com to HoldStockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a research report on Monday.October 28, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Shares Gap Down - Here's WhyCore Laboratories (NYSE:CLB) Shares Gap Down - Time to Sell?October 28, 2024 | marketbeat.comBoston Trust Walden Corp Sells 128,927 Shares of Core Laboratories Inc. (NYSE:CLB)Boston Trust Walden Corp lessened its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 17.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 600,833 shares of the oil and gas company's stock after selling 128,927 sOctober 27, 2024 | marketbeat.comEvercore ISI Remains a Hold on Core Laboratories (CLB)October 26, 2024 | markets.businessinsider.comCore Laboratories Inc (CLB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...October 25, 2024 | finance.yahoo.comCore Laboratories (CLB) Q3 2024 Earnings Call TranscriptOctober 25, 2024 | msn.comCore Laboratories Inc. Declares Quarterly Dividend of $0.01 (NYSE:CLB)Core Laboratories Inc. (NYSE:CLB) announced a quarterly dividend on Wednesday, October 23rd. Shareholders of record on Monday, November 4th will be given a dividend of 0.01 per share by the oil and gas company on Monday, November 25th. This represents a $0.04 dividend on an annualized basis and a yield of 0.21%. The ex-dividend date of this dividend is Monday, November 4th.October 24, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Issues Earnings ResultsCore Laboratories (NYSE:CLB - Get Free Report) released its earnings results on Wednesday. The oil and gas company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.04. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The business had revenue of $134.40 million for the quarter, compared to the consensus estimate of $134.16 million. During the same period last year, the business earned $0.22 earnings per share. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year.October 24, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Shares Gap Up After Better-Than-Expected EarningsCore Laboratories (NYSE:CLB) Shares Gap Up on Strong EarningsOctober 24, 2024 | marketbeat.comCore Laboratories reports Q3 ex-items EPS 25c, consensus 23cOctober 24, 2024 | markets.businessinsider.comCore Laboratories Reports Strong Q3 2024 Financial GrowthOctober 24, 2024 | markets.businessinsider.comCore Laboratories (NYSE:CLB) Issues Q4 Earnings GuidanceCore Laboratories (NYSE:CLB) updated its fourth quarter earnings guidance. The company provided EPS guidance of $0.20-0.25 for the period, compared to the consensus estimate of $0.24. The company also issued revenue guidance of $128.5-135.5 millionillion, compared to the consensus estimate of $134.60 millionillion.October 23, 2024 | marketbeat.comCORE LAB REPORTS THIRD QUARTER 2024 RESULTSOctober 23, 2024 | prnewswire.comCore Laboratories (NYSE:CLB) Shares Down 3.6% - What's Next?Core Laboratories (NYSE:CLB) Trading Down 3.6% - Here's WhyOctober 22, 2024 | marketbeat.comCore Laboratories Inc (CLB) Stock Price Up 2.76% on Oct 16October 16, 2024 | gurufocus.comCore Laboratories (NYSE:CLB) Shares Gap Down - Time to Sell?Core Laboratories (NYSE:CLB) Shares Gap Down - Here's What HappenedOctober 15, 2024 | marketbeat.comCore Laboratories (CLB) Fell Despite In-Line Earnings ResultsOctober 15, 2024 | finance.yahoo.comBWM Planning LLC Makes New $1.21 Million Investment in Core Laboratories Inc. (NYSE:CLB)BWM Planning LLC purchased a new stake in Core Laboratories Inc. (NYSE:CLB - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 65,036 shares of the oil and gas companyOctober 11, 2024 | marketbeat.comSG Americas Securities LLC Grows Position in Core Laboratories Inc. (NYSE:CLB)SG Americas Securities LLC grew its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 184.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 69,740 shares of the oil anOctober 10, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Could Be At Risk Of Shrinking As A CompanyOctober 7, 2024 | finance.yahoo.comMarshall Wace LLP Lowers Holdings in Core Laboratories Inc. (NYSE:CLB)Marshall Wace LLP reduced its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 34.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 81,052 shares of the oil and gas company's stock after selling 4October 6, 2024 | marketbeat.comEnvestnet Asset Management Inc. Has $6.22 Million Stock Position in Core Laboratories Inc. (NYSE:CLB)Envestnet Asset Management Inc. raised its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 12.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 306,287 shares of the oil andSeptember 30, 2024 | marketbeat.comDisciplined Growth Investors Inc. MN Buys 3,644,963 Shares of Core Laboratories Inc. (NYSE:CLB)Disciplined Growth Investors Inc. MN boosted its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 446.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,460,720 shares of the oil and gasSeptember 29, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Shares Acquired by Earnest Partners LLCEarnest Partners LLC raised its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 6.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,286,438 shares of the oil and gas company's stock after purchasing aSeptember 27, 2024 | marketbeat.comAriel Investments LLC Reduces Position in Core Laboratories Inc. (NYSE:CLB)Ariel Investments LLC decreased its position in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,292,296 shares of the oil and gas compSeptember 26, 2024 | marketbeat.comShort Interest in Core Laboratories Inc. (NYSE:CLB) Drops By 5.9%Core Laboratories Inc. (NYSE:CLB - Get Free Report) was the recipient of a large drop in short interest during the month of August. As of August 31st, there was short interest totalling 7,460,000 shares, a drop of 5.9% from the August 15th total of 7,930,000 shares. Based on an average daily trading volume, of 462,100 shares, the days-to-cover ratio is currently 16.1 days. Currently, 16.1% of the shares of the company are sold short.September 18, 2024 | marketbeat.comBank of New York Mellon Corp Purchases 38,726 Shares of Core Laboratories Inc. (NYSE:CLB)Bank of New York Mellon Corp boosted its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 8.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 516,119 shares of the oil and gas company's stock after acquiring an additional 38,726 sharesSeptember 10, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Given Average Rating of "Reduce" by BrokeragesShares of Core Laboratories Inc. (NYSE:CLB - Get Free Report) have been given a consensus rating of "Reduce" by the four research firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation and two have issued a holSeptember 10, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Stock Price Down 3.4%Core Laboratories (NYSE:CLB) Shares Down 3.4%September 9, 2024 | marketbeat.comCore Laboratories Inc. to Post Q4 2025 Earnings of $0.31 Per Share, Zacks Research Forecasts (NYSE:CLB)Core Laboratories Inc. (NYSE:CLB - Free Report) - Investment analysts at Zacks Research raised their Q4 2025 earnings per share (EPS) estimates for shares of Core Laboratories in a research note issued on Thursday, September 5th. Zacks Research analyst T. Saha now forecasts that the oil and gas cSeptember 9, 2024 | marketbeat.comVan ECK Associates Corp Has $10.95 Million Holdings in Core Laboratories Inc. (NYSE:CLB)Van ECK Associates Corp decreased its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 15.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 539,877 shares of the oil and gas company's stock after selling 99September 2, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Stock Price Passes Above 200 Day Moving Average of $18.21Core Laboratories (NYSE:CLB) Stock Price Passes Above Two Hundred Day Moving Average of $18.21August 30, 2024 | marketbeat.comCore Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?August 23, 2024 | uk.finance.yahoo.comCore Laboratories (CLB) Rose After Earnings BeatAugust 22, 2024 | msn.comCore Laboratories Inc. (NYSE:CLB) Sees Significant Increase in Short InterestCore Laboratories Inc. (NYSE:CLB - Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 8,200,000 shares, an increase of 12.0% from the July 15th total of 7,320,000 shares. Currently, 17.6% of the shares of the stock are sold short. Based on an average daily volume of 464,700 shares, the days-to-cover ratio is currently 17.6 days.August 17, 2024 | marketbeat.comCore Laboratories Inc. (NYSE:CLB) Given Average Recommendation of "Reduce" by BrokeragesShares of Core Laboratories Inc. (NYSE:CLB - Get Free Report) have been given a consensus rating of "Reduce" by the four research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating and two have assigned a hoAugust 16, 2024 | marketbeat.comCore Laboratories Inc. (HJ1.F)August 14, 2024 | nz.finance.yahoo.comVanguard Group Inc. Grows Stake in Core Laboratories Inc. (NYSE:CLB)Vanguard Group Inc. raised its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 0.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,392,034 shares of the oil and gas company's stock after purchasingAugust 5, 2024 | marketbeat.comPEAK6 Investments LLC Grows Stock Holdings in Core Laboratories Inc. (NYSE:CLB)PEAK6 Investments LLC boosted its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 106.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 61,005 shares of the oil and gas company's stock after buying anJuly 30, 2024 | marketbeat.comEarnest Partners LLC Trims Position in Core Laboratories Inc. (NYSE:CLB)Earnest Partners LLC lessened its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 17.1% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,090,682 shares of the oil and gas company's stocJuly 29, 2024 | marketbeat.comCore Laboratories Second Quarter 2024 Earnings: Misses ExpectationsJuly 28, 2024 | finance.yahoo.comCore Laboratories (NYSE:CLB) Price Target Raised to $22.00Stifel Nicolaus boosted their target price on Core Laboratories from $18.00 to $22.00 and gave the company a "hold" rating in a research report on Friday.July 26, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPSCore Laboratories (NYSE:CLB - Get Free Report) announced its quarterly earnings results on Wednesday. The oil and gas company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.21 by $0.01. The company had revenue of $130.58 million during the quarter, compared to analyst estimates of $132.85 million. Core Laboratories had a return on equity of 15.71% and a net margin of 8.18%. The firm's revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.23 earnings per share.July 25, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Shares Up 9.4% on Better-Than-Expected EarningsCore Laboratories (NYSE:CLB) Stock Price Up 9.4% Following Strong EarningsJuly 25, 2024 | marketbeat.comCore Laboratories (NYSE:CLB) Updates Q3 Earnings GuidanceCore Laboratories (NYSE:CLB) updated its third quarter earnings guidance. The company provided EPS guidance of $0.23-0.27 for the period, compared to the consensus estimate of $0.24. The company also issued revenue guidance of $131-137 millionillion, compared to the consensus estimate of $136.07 millionillion.July 24, 2024 | marketbeat.comCORE LAB REPORTS SECOND QUARTER 2024 RESULTSJuly 24, 2024 | prnewswire.com Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address 2024's Must-Watch Stocks! (Ad)Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] CLB Media Mentions By Week CLB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CLB News Sentiment▼0.840.59▲Average Oils/Energy News Sentiment CLB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CLB Articles This Week▼23▲CLB Articles Average Week Get Core Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for CLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BSM News SSL News VRN News LBRT News CRGY News TALO News CLMT News HPK News WTTR News DMLP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CLB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
